Treating mice with IL-18 BP at days 2 and 3 post-CR infection inhibited ILC2s expansion, and treating Il22-/- mice with rIL-18 rescued ILC2s expansion, together providing direct evidence that IL-18 plays a key role in ILC2s expansion during infection. Here, IL18 is linked to infection.